BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27814720)

  • 21. miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer.
    Li W; Wang H; Zhang J; Zhai L; Chen W; Zhao C
    Cancer Sci; 2016 Jul; 107(7):916-23. PubMed ID: 27094578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.
    Xie F; Li Y; Wang M; Huang C; Tao D; Zheng F; Zhang H; Zeng F; Xiao X; Jiang G
    Mol Cancer; 2018 Oct; 17(1):144. PubMed ID: 30285878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
    Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair.
    Li W; Xue W; Wang X; Fu X; Sun Z; Li Z; Chang Y; Zhang X; Zhou Z; Chen C; Zhang M
    Anticancer Drugs; 2018 Oct; 29(9):861-870. PubMed ID: 29979193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
    Cao W; Zhao Y; Wang L; Huang X
    Cancer Biomark; 2019; 25(1):101-113. PubMed ID: 30909190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
    Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.
    Lin HS; Gong JN; Su R; Chen MT; Song L; Shen C; Wang F; Ma YN; Zhao HL; Yu J; Li WW; Huang LX; Xu XH; Zhang JW
    J Leukoc Biol; 2014 Dec; 96(6):1023-35. PubMed ID: 25258381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
    Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
    Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1.
    Liu J; Cao J; Zhao X
    BMC Urol; 2015 Apr; 15():36. PubMed ID: 25928257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.
    Liu X; Yao B; Wu Z
    Oncol Lett; 2018 Oct; 16(4):4543-4550. PubMed ID: 30214589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
    Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-211-5p is down-regulated and a prognostic marker in bladder cancer.
    Wang W; Liu Z; Zhang X; Liu J; Gui J; Cui M; Li Y
    J Gene Med; 2020 Dec; 22(12):e3270. PubMed ID: 32893379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
    Chen Z; Li Q; Wang S; Zhang J
    Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency.
    Hassan T; Carroll TP; Buckley PG; Cummins R; O'Neill SJ; McElvaney NG; Greene CM
    Am J Respir Crit Care Med; 2014 Feb; 189(3):263-73. PubMed ID: 24299514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-199a-3p/5p participated in TGF-β and EGF induced EMT by targeting DUSP5/MAP3K11 in pterygium.
    He S; Huang Y; Dong S; Qiao C; Yang G; Zhang S; Wang C; Xu Y; Zheng F; Yan M
    J Transl Med; 2020 Sep; 18(1):332. PubMed ID: 32867783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.